tiprankstipranks
Percheron Therapeutics (AU:PER)
ASX:PER
Australian Market
Want to see AU:PER full AI Analyst Report?

Percheron Therapeutics (PER) Financial Statements

13 Followers

Percheron Therapeutics Financial Overview

Percheron Therapeutics's market cap is currently AU$7.61M. The company's EPS TTM is AU$-0.0041; its P/E ratio is -1.22; Percheron Therapeutics is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross ProfitAU$ -219.56KAU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22K
Operating IncomeAU$ -5.62MAU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61M
EBITDAAU$ -5.40MAU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52M
Net IncomeAU$ -4.79MAU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.05MAU$ 10.17MAU$ 11.87MAU$ 10.97MAU$ 19.23M
Total AssetsAU$ 8.22MAU$ 12.44MAU$ 14.53MAU$ 12.84MAU$ 22.44M
Total DebtAU$ 27.79KAU$ 25.86KAU$ 39.87KAU$ 142.10KAU$ 227.40K
Net DebtAU$ -2.52MAU$ -10.14MAU$ -11.83MAU$ -10.83MAU$ -19.01M
Total LiabilitiesAU$ 692.18KAU$ 2.43MAU$ 5.17MAU$ 2.87MAU$ 1.30M
Stockholders' EquityAU$ 7.53MAU$ 10.00MAU$ 9.36MAU$ 9.98MAU$ 21.14M
Cash Flow
Free Cash FlowAU$ -4.97MAU$ -15.65MAU$ -10.12MAU$ -8.18MAU$ -7.81M
Operating Cash FlowAU$ -4.96MAU$ -15.64MAU$ -10.12MAU$ -8.15MAU$ -7.81M
Investing Cash FlowAU$ -3.09MAU$ -7.24KAU$ -3.61KAU$ -29.29KAU$ -3.91K
Financing Cash FlowAU$ 1.93MAU$ 13.95MAU$ 11.02MAU$ -85.30KAU$ 21.02M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History

Percheron Therapeutics Debt to Assets

Percheron Therapeutics Cash Flow

Percheron Therapeutics Forecast EPS vs Actual EPS